Cell-based Quadrivalent Influenza Vaccine
A Voluntary Ex-Ante Transparency (VEAT) Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")
- Source
- Find a Tender
- Type
- Contract (Supply)
- Duration
- not specified
- Value
- £15M
- Sector
- HEALTH
- Published
- 05 Apr 2022
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
Movianto, Unit1, Haydock Green, PennyLane, Haydock, WA119DT
Geochart for 2 buyers and 1 suppliers
2 buyers
- NHS National Services Scotland NSS Edinburgh
1 supplier
- Seqirus Liverpool
Description
This procurement is for the supply of cell-based quadrivalent influenza vaccine to NHSScotland for use in the annual seasonal influenza immunisation programme.
Total Quantity or Scope
This procurement is for the supply of cell-based quadrivalent influenza vaccine for use in the annual seasonal influenza immunisation programme.
Award Detail
| 1 | Seqirus (Liverpool)
|
CPV Codes
- 33651660 - Influenza vaccines
Indicators
Legal Justification
Seqirus UK Limited are currently the sole supplier of cell-based quadrivalent influenza vaccines for which no direct competition exists.
Other Information
The values referred to in sections II.1.7 and V.2.4 cover the full twelve (12) month duration of the contract. (SC Ref:686765)
Reference
- FTS 009068-2022